| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/19/1992 | EP0498820A1 Echinoderm agglutinin and method of extraction |
| 08/19/1992 | EP0449956A4 Novel lymphokine/cytokine genes |
| 08/19/1992 | EP0340245B1 Substituted alkylamides of teicoplanin compounds |
| 08/19/1992 | EP0305401B1 Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| 08/19/1992 | EP0153961B1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof |
| 08/19/1992 | CN1063691A Amino acid derivatives process for preparation thereof and pharmaceutical composition comprising same |
| 08/19/1992 | CN1017867B Method of preparing covaluently-modified neutral bacterial poly-saccharides and thereof covalent conjugates of such polysaccharides and immunogenic protein |
| 08/18/1992 | US5140105 Purified and isolated HIV protein; reacts with monoclonal anti-monoclonal-anti-human lymphocyte T4 antibodies |
| 08/18/1992 | US5140103 Quanitative analysis of telopeptides crosslinked by hydroxylysyl pyridinoline(HP) or lysyl pyridinoline(LP) derived from bone collagen reabsorption |
| 08/18/1992 | US5140100 Isolated from human decidual cells with molecular weight of from 7000 to 10000 daltons |
| 08/18/1992 | US5140009 Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders |
| 08/18/1992 | US5139954 External control of selected genes in plant cells by use of nucleic acid promoter fragments |
| 08/18/1992 | US5139953 For specific adsorption of minor constituents in a liquid containing immobilized enzymes and carriers |
| 08/18/1992 | US5139950 PTR2030, a conjugal plasmid and derivatives thereof that confer phage resistance to group N streptococci |
| 08/18/1992 | US5139947 Antigenic noninfectious hiv-producing cloned t cell |
| 08/18/1992 | US5139937 Process for producing apoaequorin |
| 08/18/1992 | US5139936 Use of the GAL1 yeast promoter |
| 08/18/1992 | CA1306583C Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 08/18/1992 | CA1306582C Synthetic polypeptides for detecting mycobacterial infections |
| 08/18/1992 | CA1306581C Platelet binding inhibitors |
| 08/18/1992 | CA1306428C Monoclonal antibody specific for a mammary tumor cell surface antigen |
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein |
| 08/16/1992 | CA2061266A1 Recombinant dna molecules coding for a sequence of the t-cell antigen receptor, process for its preparation, and antibodies and medicament containing them |
| 08/16/1992 | CA2061246A1 Peptides having antagonistic activities to endothelin receptors, production and use thereof |
| 08/16/1992 | CA2061211A1 Stimulation of endosteal bone formation |
| 08/15/1992 | WO1992014755A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 08/15/1992 | CA2101919A1 Integrin specificity for the hiv tat protein |
| 08/13/1992 | WO1992013881A1 Peptides |
| 08/13/1992 | WO1992013560A1 Reagents and methods for identification of vaccines |
| 08/13/1992 | DE4104240A1 Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren Receptors cloning of a new member of the family of fibroblast growth factors (FGF) |
| 08/13/1992 | DE4103649A1 Neue antikoagulatorisch wirksame peptide New anticoagulatory peptide |
| 08/13/1992 | CA2103788A1 Reagents and methods for identification of vaccines |
| 08/13/1992 | CA2103703A1 Peptides |
| 08/12/1992 | EP0498784A2 Inhibitors of retroviral protease |
| 08/12/1992 | EP0498771A2 MSH peptide derivatives |
| 08/12/1992 | EP0498658A2 Composition for inducing humoral anergy to an immunogen |
| 08/12/1992 | EP0498537A2 Novel coleopteran-active bacillus thuringiensis isolate and a novel gene encoding a coleopteran-active toxin |
| 08/12/1992 | EP0498508A1 Factor IIa inhibitors |
| 08/12/1992 | EP0498222A1 Novel peptides |
| 08/12/1992 | EP0498133A1 Process for the purification of human albumin |
| 08/12/1992 | EP0497950A1 Mutation of hrv2 2a |
| 08/12/1992 | EP0497929A1 Composition for stabilizing blood plasma during pasteurization. |
| 08/12/1992 | EP0497928A1 Yeast-derived epidermal growth factor/urogastrone-like products |
| 08/12/1992 | EP0497922A1 Infective protein delivery system |
| 08/12/1992 | EP0497916A1 Expression of bacterial hemoglobin and enhancement of expression of cloned and native products in streptomyces |
| 08/12/1992 | EP0497915A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE. |
| 08/12/1992 | EP0497904A1 Compositions containing plant-produced glycopolypeptide multimers and methods for their production |
| 08/12/1992 | EP0497897A1 Diagnosis of glomerulonephritis |
| 08/12/1992 | EP0497892A1 Dna molecules improving cold-resistance |
| 08/12/1992 | EP0497884A1 Glutamate receptor compositions and methods |
| 08/12/1992 | EP0497883A1 Compositions and their use for promoting immunopotentiation |
| 08/12/1992 | EP0497867A1 Polypeptide inhibitors of gamma interferon |
| 08/12/1992 | EP0497866A1 Gastrin releasing peptide receptor |
| 08/12/1992 | EP0497835A1 Method for treating hiv and other retroviruses and compounds useful therefor |
| 08/12/1992 | EP0497833A1 C1 inhibitor muteins and uses thereof |
| 08/12/1992 | EP0497794A1 A microperoxidase preparation containing a hemopeptide as an active component. |
| 08/12/1992 | EP0497771A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 08/12/1992 | EP0489780A4 Fusion proteins, their preparation and use |
| 08/12/1992 | EP0489062A4 Bone-specific protein |
| 08/12/1992 | EP0463081A4 Hormone response element compositions and assay |
| 08/12/1992 | EP0456766A4 Type oc platelet-derived growth factor receptor gene |
| 08/12/1992 | EP0160699B1 Production of heterodimeric human fertlity hormones |
| 08/12/1992 | CN1063507A Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 08/12/1992 | CN1063416A Avirulent microbes and uses therefor:salmonella typhi |
| 08/12/1992 | CA2060741A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2060699A1 Gm-csf inhibiting oligopeptides |
| 08/11/1992 | US5138061 For introducing thioamide bonds into growing peptides |
| 08/11/1992 | US5138035 Enzyme inhibitors |
| 08/11/1992 | US5138034 Freezing, ethanol extraction, ion exchanging, chromatography |
| 08/11/1992 | US5138033 Marek's disease herpesvirus glycoproteins GE |
| 08/11/1992 | US5137874 For parenteral administration |
| 08/11/1992 | US5137872 Growth hormone-releasing factor analogs |
| 08/11/1992 | US5137871 Treatment to reduce edema for brain and musculature injuries |
| 08/11/1992 | US5137824 Csf-1 gene promoter |
| 08/11/1992 | US5137821 Gene and process of making glucose-6-phosphate dehydrogenase |
| 08/11/1992 | US5137819 Cellulose binding fusion proteins for immobilization and purification of polypeptides |
| 08/11/1992 | US5137816 Controlled gene expression |
| 08/11/1992 | US5137805 Method of diagnosing stress condition by specific binding of human heat shock factor |
| 08/11/1992 | US5137721 Vaccine for preventionof gastointestinal disorder |
| 08/11/1992 | CA1306212C Insulin analogues and process for their preparation |
| 08/11/1992 | CA1306211C Pichia pastoris alcohol oxidase ii regulatory region |
| 08/11/1992 | CA1306210C Bacillus thuringiensis gene encoding a coleopteran-active toxin |
| 08/11/1992 | CA1306209C Fused antigen polypeptide |
| 08/11/1992 | CA1306208C Enhanced expression and stabilization of gene products in microorganisms using short selected leader signal sequences |
| 08/11/1992 | CA1306207C Polypeptide and protein products, and process for their production and use |
| 08/11/1992 | CA1306194C Use of amphipathic molecules for radio-imaging and therapy with conjugates of monoclonal or polyclonal antibodies |
| 08/11/1992 | CA1306191C Hiv gp160 aids virus envelope protein-containing strips and use thereof for detection of aids antibody |
| 08/10/1992 | CA2060856A1 Amino acid derivatives |
| 08/09/1992 | WO1992013946A1 Htlv-i and htlv-ii peptide antigens and methods |
| 08/09/1992 | WO1992013558A1 A composition for inducing humoral anergy |
| 08/09/1992 | CA2060864A1 Non-a, non-b hepatitis related nucleic acids, agents antibodies and their detection reagents |
| 08/08/1992 | CA2060785A1 Inhibitors of retroviral protease |
| 08/06/1992 | WO1992013103A1 Inherited and somatic mutations of apc gene in colorectal cancer of humans |
| 08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
| 08/06/1992 | WO1992013093A1 Antigen recognized by patients with antibody associated cerebellar degeneration, dna encoding same and uses thereof |
| 08/06/1992 | WO1992013092A1 Methods of transcriptionally modulating expression of hematopoietic growth factor genes |
| 08/06/1992 | WO1992013091A1 Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes |
| 08/06/1992 | WO1992013090A1 Trans-splicing ribozymes |
| 08/06/1992 | WO1992013083A1 Nucleic acid encoding insulin receptor substrate-1 (irs-1), irs-1 protein, diseases, therapy associated with the metabolism of irs-1 |
| 08/06/1992 | WO1992013081A1 Antigen-presenting capsid with fusion ms2-coat protein |